BlackRock Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

BlackRock Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$656K	Buy	18,864 +188	+1%	+$5.62K	﹤0.01%	2060
2016 Q3	$458K	Sell	18,676 -46,101	-71%	-$1.15M	﹤0.01%	2222
2016 Q2	$1.55M	Sell	64,777 -22,405	-26%	-$514K	﹤0.01%	1557
2016 Q1	$2.04M	Buy	87,182 +36,845	+73%	+$874K	﹤0.01%	1410
2015 Q4	$1.52M	Buy	50,337 +38,223	+316%	+$1.23M	﹤0.01%	1519
2015 Q3	$481K	Hold	12,114	–	–	﹤0.01%	2218
2015 Q2	$837K	Hold	12,114	–	–	﹤0.01%	1789
2015 Q1	$662K	Hold	12,114	–	–	﹤0.01%	1867
2014 Q4	$516K	Sell	12,114 -912	-7%	-$33K	﹤0.01%	1979
2014 Q3	$416K	Sell	13,026 -141	-1%	-$3.01K	﹤0.01%	2114
2014 Q2	$273K	Sell	13,167 -52,263	-80%	-$966K	﹤0.01%	2445
2014 Q1	$1.27M	Buy	65,430 +14,644	+29%	+$311K	﹤0.01%	1389
2013 Q4	$1.23M	Buy	50,786 +12,770	+34%	+$300K	﹤0.01%	1384
2013 Q3	$816K	Buy	38,016 +24,867	+189%	+$588K	﹤0.01%	1548
2013 Q2	$293K	Buy	+13,149	New	+$290K	﹤0.01%	2224

Other funds holding AMAG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Advisors's AMAG Position: Q4 2016 in Review

BlackRock Advisors increased its AMAG Pharmaceuticals (AMAG) stake by 1% in Q4 2016, buying an estimated $5.62K and bringing the position to 18,864 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

BlackRock Advisors first reported a position in AMAG in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.04M in Q1 2016. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

BlackRock Advisors held 18,864 shares of AMAG Pharmaceuticals worth $656K as of Q4 2016.
BlackRock Advisors bought 188 AMAG Pharmaceuticals shares in Q4 2016, an estimated $5.62K.
AMAG Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2060 holding.
BlackRock Advisors first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's AMAG Pharmaceuticals position peaked at $2.04M in Q1 2016.
206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.